Cargando…

Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey

BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HR...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankowska, Agnieszka, Młyńczak, Katarzyna, Golicki, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097836/
https://www.ncbi.nlm.nih.gov/pubmed/33952271
http://dx.doi.org/10.1186/s12955-021-01780-2
_version_ 1783688393500131328
author Jankowska, Agnieszka
Młyńczak, Katarzyna
Golicki, Dominik
author_facet Jankowska, Agnieszka
Młyńczak, Katarzyna
Golicki, Dominik
author_sort Jankowska, Agnieszka
collection PubMed
description BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HRQoL instruments (EQ-5D-5L, EQ VAS, SF-12, EQ-5D-3L) and a screening question about diabetes. To obtain EQ-5D index values, we used country-specific Polish value sets. We compared the instruments in terms of the ceiling effect, discriminatory power and frequency of individual health states. We evaluated construct validity in terms of known-groups validity and convergent validity of EQ-5D-5L dimensions and index values with other HRQoL measures. RESULTS: In respondents with diabetes (n = 247), the percentage reporting 'no problems' with EQ-5D-3L was reduced by 34.5% with the use of EQ-5D-5L (from 14.2% to 9.3%, respectively). A significant improvement in informativity was noticed in mobility and pain/discomfort dimensions (a relative increase of 23.1% and 22.7%, respectively). Known-groups construct validity analysis confirmed prior hypotheses—index scores were higher in the following groups: younger respondents, males, those taking no medication or oral antidiabetic drugs, and respondents with higher levels of education. The convergence between related EQ-5D-5L and EQ-5D-3L or SF-6D dimensions was stronger than between unrelated dimensions. The Bland–Altman analysis showed a mean difference between EQ-5D-5L and EQ-5D-3L, SF-6D, EQ VAS/100 index scores of 0.047, 0.165 and 0.231 respectively. CONCLUSIONS: Our results support the validity of the EQ-5D-5L descriptive system and EQ-5D-5L index, based on the directly measured value set in respondents with self-reported diabetes coming from the general population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01780-2.
format Online
Article
Text
id pubmed-8097836
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80978362021-05-05 Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey Jankowska, Agnieszka Młyńczak, Katarzyna Golicki, Dominik Health Qual Life Outcomes Research BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HRQoL instruments (EQ-5D-5L, EQ VAS, SF-12, EQ-5D-3L) and a screening question about diabetes. To obtain EQ-5D index values, we used country-specific Polish value sets. We compared the instruments in terms of the ceiling effect, discriminatory power and frequency of individual health states. We evaluated construct validity in terms of known-groups validity and convergent validity of EQ-5D-5L dimensions and index values with other HRQoL measures. RESULTS: In respondents with diabetes (n = 247), the percentage reporting 'no problems' with EQ-5D-3L was reduced by 34.5% with the use of EQ-5D-5L (from 14.2% to 9.3%, respectively). A significant improvement in informativity was noticed in mobility and pain/discomfort dimensions (a relative increase of 23.1% and 22.7%, respectively). Known-groups construct validity analysis confirmed prior hypotheses—index scores were higher in the following groups: younger respondents, males, those taking no medication or oral antidiabetic drugs, and respondents with higher levels of education. The convergence between related EQ-5D-5L and EQ-5D-3L or SF-6D dimensions was stronger than between unrelated dimensions. The Bland–Altman analysis showed a mean difference between EQ-5D-5L and EQ-5D-3L, SF-6D, EQ VAS/100 index scores of 0.047, 0.165 and 0.231 respectively. CONCLUSIONS: Our results support the validity of the EQ-5D-5L descriptive system and EQ-5D-5L index, based on the directly measured value set in respondents with self-reported diabetes coming from the general population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01780-2. BioMed Central 2021-05-05 /pmc/articles/PMC8097836/ /pubmed/33952271 http://dx.doi.org/10.1186/s12955-021-01780-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jankowska, Agnieszka
Młyńczak, Katarzyna
Golicki, Dominik
Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title_full Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title_fullStr Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title_full_unstemmed Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title_short Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
title_sort validity of eq-5d-5l health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097836/
https://www.ncbi.nlm.nih.gov/pubmed/33952271
http://dx.doi.org/10.1186/s12955-021-01780-2
work_keys_str_mv AT jankowskaagnieszka validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey
AT młynczakkatarzyna validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey
AT golickidominik validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey